HEADER TRANSFERASE 13-DEC-16 5MO4 TITLE ABL1 KINASE (T334I_D382N) IN COMPLEX WITH ASCIMINIB AND NILOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, DRUG, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB REVDAT 2 12-APR-17 5MO4 1 JRNL REVDAT 1 05-APR-17 5MO4 0 JRNL AUTH A.A.WYLIE,J.SCHOEPFER,W.JAHNKE,S.W.COWAN-JACOB,A.LOO, JRNL AUTH 2 P.FURET,A.L.MARZINZIK,X.PELLE,J.DONOVAN,W.ZHU,S.BUONAMICI, JRNL AUTH 3 A.Q.HASSAN,F.LOMBARDO,V.IYER,M.PALMER,G.BERELLINI,S.DODD, JRNL AUTH 4 S.THOHAN,H.BITTER,S.BRANFORD,D.M.ROSS,T.P.HUGHES, JRNL AUTH 5 L.PETRUZZELLI,K.G.VANASSE,M.WARMUTH,F.HOFMANN,N.J.KEEN, JRNL AUTH 6 W.R.SELLERS JRNL TITL THE ALLOSTERIC INHIBITOR ABL001 ENABLES DUAL TARGETING OF JRNL TITL 2 BCR-ABL1. JRNL REF NATURE V. 543 733 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28329763 JRNL DOI 10.1038/NATURE21702 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 29028 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1439 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2799 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2283 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2668 REMARK 3 BIN R VALUE (WORKING SET) : 0.2272 REMARK 3 BIN FREE R VALUE : 0.2520 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.68 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3385 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 307 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.15670 REMARK 3 B22 (A**2) : 2.19600 REMARK 3 B33 (A**2) : -6.35270 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.218 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.173 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.170 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3560 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4848 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1175 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 77 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 520 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3560 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 443 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4126 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.19 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.40 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MO4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1200002750. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC, XDS (VERSION DECEMBER REMARK 200 6 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29197 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.166 REMARK 200 RESOLUTION RANGE LOW (A) : 59.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.59900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: FLAT RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 18 % (W/V) PEG 3350, 0.2 M REMARK 280 POTASSIUM FORMATE, 0.1 M TRIS PH 7.5 PROTEIN: 35.7 MG/ML 20 MM REMARK 280 TRIS PH 8, 200 MM NACL, 2 MM TCEP PROTOCOL: 0.6 UL PROTEIN REMARK 280 SOLUTION PLUS 0.6 UL RESERVOIR SOLUTION, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.33000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.33000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.14000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.06500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.14000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.06500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.33000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.14000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.06500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.33000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.14000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.06500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 957 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 40 REMARK 465 ALA A 41 REMARK 465 MET A 42 REMARK 465 ASP A 43 REMARK 465 PRO A 44 REMARK 465 SER A 45 REMARK 465 GLU A 46 REMARK 465 ALA A 47 REMARK 465 LEU A 48 REMARK 465 GLN A 49 REMARK 465 ARG A 50 REMARK 465 PRO A 51 REMARK 465 VAL A 52 REMARK 465 ALA A 53 REMARK 465 SER A 54 REMARK 465 ASP A 55 REMARK 465 PHE A 56 REMARK 465 GLU A 57 REMARK 465 PRO A 58 REMARK 465 GLN A 59 REMARK 465 GLY A 60 REMARK 465 LEU A 61 REMARK 465 SER A 62 REMARK 465 GLU A 63 REMARK 465 ALA A 64 REMARK 465 ALA A 65 REMARK 465 ARG A 66 REMARK 465 TRP A 67 REMARK 465 ASN A 68 REMARK 465 SER A 69 REMARK 465 LYS A 70 REMARK 465 GLU A 71 REMARK 465 ASN A 72 REMARK 465 LEU A 73 REMARK 465 LEU A 74 REMARK 465 ALA A 75 REMARK 465 GLY A 76 REMARK 465 PRO A 77 REMARK 465 SER A 78 REMARK 465 GLU A 79 REMARK 465 ASN A 80 REMARK 465 ASP A 81 REMARK 465 PRO A 82 REMARK 465 THR A 296 REMARK 465 MET A 297 REMARK 465 GLY A 402 REMARK 465 LEU A 403 REMARK 465 SER A 404 REMARK 465 ARG A 405 REMARK 465 LEU A 406 REMARK 465 MET A 407 REMARK 465 THR A 408 REMARK 465 GLY A 409 REMARK 465 ASP A 410 REMARK 465 THR A 411 REMARK 465 TYR A 412 REMARK 465 THR A 413 REMARK 465 ALA A 414 REMARK 465 HIS A 415 REMARK 465 ALA A 416 REMARK 465 GLY A 417 REMARK 465 ALA A 418 REMARK 465 LYS A 419 REMARK 465 GLN A 532 REMARK 465 GLY A 533 REMARK 465 VAL A 534 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 96 CG OD1 OD2 REMARK 470 LYS A 124 CE NZ REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 GLN A 179 CG CD OE1 NE2 REMARK 470 ARG A 194 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 253 CG CD CE NZ REMARK 470 LYS A 282 CG CD CE NZ REMARK 470 LYS A 293 CG CD CE NZ REMARK 470 GLU A 298 CG CD OE1 OE2 REMARK 470 GLU A 300 CG CD OE1 OE2 REMARK 470 GLU A 301 CG CD OE1 OE2 REMARK 470 GLN A 352 CG CD OE1 NE2 REMARK 470 LYS A 375 CG CD CE NZ REMARK 470 PHE A 420 CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 434 CE NZ REMARK 470 GLN A 466 CG CD OE1 NE2 REMARK 470 GLU A 478 CG CD OE1 OE2 REMARK 470 GLU A 485 CG CD OE1 OE2 REMARK 470 GLU A 518 CG CD OE1 OE2 REMARK 470 GLU A 526 CG CD OE1 OE2 REMARK 470 LYS A 527 CG CD CE NZ REMARK 470 LYS A 531 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 94 -62.81 -127.91 REMARK 500 THR A 123 -169.93 -120.02 REMARK 500 ASN A 139 51.54 -94.89 REMARK 500 ASP A 226 58.46 36.46 REMARK 500 ASP A 252 29.11 46.31 REMARK 500 LYS A 264 -153.63 -103.98 REMARK 500 TRP A 280 74.24 -111.65 REMARK 500 ARG A 381 -12.21 73.57 REMARK 500 TRP A 495 31.04 -94.44 REMARK 500 PHE A 516 55.88 -119.36 REMARK 500 GLU A 518 44.03 -144.03 REMARK 500 SER A 519 -171.77 -177.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1007 DISTANCE = 6.35 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NIL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AY7 A 602 DBREF 5MO4 A 46 534 UNP P00519 ABL1_HUMAN 27 515 SEQADV 5MO4 GLY A 40 UNP P00519 EXPRESSION TAG SEQADV 5MO4 ALA A 41 UNP P00519 EXPRESSION TAG SEQADV 5MO4 MET A 42 UNP P00519 EXPRESSION TAG SEQADV 5MO4 ASP A 43 UNP P00519 EXPRESSION TAG SEQADV 5MO4 PRO A 44 UNP P00519 EXPRESSION TAG SEQADV 5MO4 SER A 45 UNP P00519 EXPRESSION TAG SEQADV 5MO4 ILE A 334 UNP P00519 THR 315 CONFLICT SEQADV 5MO4 ASN A 382 UNP P00519 ASP 363 CONFLICT SEQRES 1 A 495 GLY ALA MET ASP PRO SER GLU ALA LEU GLN ARG PRO VAL SEQRES 2 A 495 ALA SER ASP PHE GLU PRO GLN GLY LEU SER GLU ALA ALA SEQRES 3 A 495 ARG TRP ASN SER LYS GLU ASN LEU LEU ALA GLY PRO SER SEQRES 4 A 495 GLU ASN ASP PRO ASN LEU PHE VAL ALA LEU TYR ASP PHE SEQRES 5 A 495 VAL ALA SER GLY ASP ASN THR LEU SER ILE THR LYS GLY SEQRES 6 A 495 GLU LYS LEU ARG VAL LEU GLY TYR ASN HIS ASN GLY GLU SEQRES 7 A 495 TRP CYS GLU ALA GLN THR LYS ASN GLY GLN GLY TRP VAL SEQRES 8 A 495 PRO SER ASN TYR ILE THR PRO VAL ASN SER LEU GLU LYS SEQRES 9 A 495 HIS SER TRP TYR HIS GLY PRO VAL SER ARG ASN ALA ALA SEQRES 10 A 495 GLU TYR LEU LEU SER SER GLY ILE ASN GLY SER PHE LEU SEQRES 11 A 495 VAL ARG GLU SER GLU SER SER PRO GLY GLN ARG SER ILE SEQRES 12 A 495 SER LEU ARG TYR GLU GLY ARG VAL TYR HIS TYR ARG ILE SEQRES 13 A 495 ASN THR ALA SER ASP GLY LYS LEU TYR VAL SER SER GLU SEQRES 14 A 495 SER ARG PHE ASN THR LEU ALA GLU LEU VAL HIS HIS HIS SEQRES 15 A 495 SER THR VAL ALA ASP GLY LEU ILE THR THR LEU HIS TYR SEQRES 16 A 495 PRO ALA PRO LYS ARG ASN LYS PRO THR VAL TYR GLY VAL SEQRES 17 A 495 SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR ASP SEQRES 18 A 495 ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY SEQRES 19 A 495 GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU THR SEQRES 20 A 495 VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU VAL SEQRES 21 A 495 GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU ILE SEQRES 22 A 495 LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS THR SEQRES 23 A 495 ARG GLU PRO PRO PHE TYR ILE ILE ILE GLU PHE MET THR SEQRES 24 A 495 TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG SEQRES 25 A 495 GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA THR SEQRES 26 A 495 GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS ASN SEQRES 27 A 495 PHE ILE HIS ARG ASN LEU ALA ALA ARG ASN CYS LEU VAL SEQRES 28 A 495 GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 29 A 495 SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS ALA SEQRES 30 A 495 GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SER SEQRES 31 A 495 LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL TRP SEQRES 32 A 495 ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR GLY SEQRES 33 A 495 MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL TYR SEQRES 34 A 495 GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO GLU SEQRES 35 A 495 GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA CYS SEQRES 36 A 495 TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA GLU SEQRES 37 A 495 ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SER SEQRES 38 A 495 ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS GLN GLY SEQRES 39 A 495 VAL HET NIL A 601 39 HET AY7 A 602 31 HETNAM NIL NILOTINIB HETNAM AY7 ASCIMINIB HETSYN NIL 4-METHYL-N-[3-(4-METHYL-1H-IMIDAZOL-1-YL)-5- HETSYN 2 NIL (TRIFLUOROMETHYL)PHENYL]-3-[(4-PYRIDIN-3-YLPYRIMIDIN- HETSYN 3 NIL 2-YL)AMINO]BENZAMIDE FORMUL 2 NIL C28 H22 F3 N7 O FORMUL 3 AY7 C20 H18 CL F2 N5 O3 FORMUL 4 HOH *307(H2 O) HELIX 1 AA1 SER A 140 HIS A 144 5 5 HELIX 2 AA2 SER A 152 SER A 161 1 10 HELIX 3 AA3 THR A 213 SER A 222 1 10 HELIX 4 AA4 GLU A 257 THR A 259 5 3 HELIX 5 AA5 GLY A 268 GLN A 271 5 4 HELIX 6 AA6 LYS A 282 SER A 284 5 3 HELIX 7 AA7 VAL A 299 GLU A 311 1 13 HELIX 8 AA8 ASN A 341 CYS A 349 1 9 HELIX 9 AA9 ASN A 355 LYS A 376 1 22 HELIX 10 AB1 ALA A 384 ARG A 386 5 3 HELIX 11 AB2 GLU A 392 HIS A 394 5 3 HELIX 12 AB3 PHE A 420 THR A 425 5 6 HELIX 13 AB4 ALA A 426 ASN A 433 1 8 HELIX 14 AB5 SER A 436 THR A 453 1 18 HELIX 15 AB6 GLN A 466 LYS A 473 1 8 HELIX 16 AB7 PRO A 484 TRP A 495 1 12 HELIX 17 AB8 ASN A 498 ARG A 502 5 5 HELIX 18 AB9 SER A 504 THR A 514 1 11 HELIX 19 AC1 SER A 520 LYS A 531 1 12 SHEET 1 AA1 5 GLN A 127 PRO A 131 0 SHEET 2 AA1 5 TRP A 118 GLN A 122 -1 N ALA A 121 O GLY A 128 SHEET 3 AA1 5 LYS A 106 TYR A 112 -1 N GLY A 111 O GLU A 120 SHEET 4 AA1 5 LEU A 84 ALA A 87 -1 N PHE A 85 O LEU A 107 SHEET 5 AA1 5 ILE A 135 PRO A 137 -1 O THR A 136 N VAL A 86 SHEET 1 AA2 4 TYR A 147 PRO A 150 0 SHEET 2 AA2 4 SER A 167 GLU A 172 1 O GLU A 172 N GLY A 149 SHEET 3 AA2 4 ARG A 180 TYR A 186 -1 O ARG A 185 N SER A 167 SHEET 4 AA2 4 ARG A 189 ARG A 194 -1 O TYR A 191 N LEU A 184 SHEET 1 AA3 3 TYR A 147 PRO A 150 0 SHEET 2 AA3 3 SER A 167 GLU A 172 1 O GLU A 172 N GLY A 149 SHEET 3 AA3 3 TYR A 234 PRO A 235 1 O TYR A 234 N PHE A 168 SHEET 1 AA4 2 ASN A 196 THR A 197 0 SHEET 2 AA4 2 LEU A 203 TYR A 204 -1 O TYR A 204 N ASN A 196 SHEET 1 AA5 5 ILE A 261 LYS A 266 0 SHEET 2 AA5 5 VAL A 275 TRP A 280 -1 O GLU A 277 N LYS A 264 SHEET 3 AA5 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280 SHEET 4 AA5 5 TYR A 331 GLU A 335 -1 O ILE A 334 N ALA A 288 SHEET 5 AA5 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 AA6 2 CYS A 388 VAL A 390 0 SHEET 2 AA6 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 CISPEP 1 PRO A 328 PRO A 329 0 -3.95 SITE 1 AC1 20 TYR A 272 ALA A 288 LYS A 290 GLU A 305 SITE 2 AC1 20 VAL A 308 MET A 309 ILE A 312 LEU A 317 SITE 3 AC1 20 VAL A 318 ILE A 332 ILE A 334 PHE A 336 SITE 4 AC1 20 MET A 337 PHE A 378 HIS A 380 LEU A 389 SITE 5 AC1 20 ALA A 399 ASP A 400 PHE A 401 HOH A 872 SITE 1 AC2 17 ALA A 356 LEU A 359 LEU A 360 ALA A 363 SITE 2 AC2 17 LEU A 448 ILE A 451 ALA A 452 THR A 453 SITE 3 AC2 17 GLU A 481 VAL A 487 PHE A 512 ILE A 521 SITE 4 AC2 17 VAL A 525 HOH A 715 HOH A 768 HOH A 866 SITE 5 AC2 17 HOH A 874 CRYST1 118.280 124.130 74.660 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008455 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008056 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013394 0.00000